Annual report pursuant to Section 13 and 15(d)

Income Taxes - Schedule of Deferred Income Tax Assets (Details)

v3.24.0.1
Income Taxes - Schedule of Deferred Income Tax Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets:      
Net operating loss carryforwards $ 138,735 $ 161,239 $ 124,591
Research and development credits 55,492 36,886 22,995
Accruals and reserves 2,479 148 518
Property and equipment 3,110 4,260 1,362
Stock-based compensation 16,396 14,416 4,651
Goodwill 4,311 4,920 3,819
Intangibles 2,234 900 355
Lease Liability 664 600 0
Capitalized R&D 88,985 42,676 0
Total deferred tax assets 312,406 266,045 158,291
Valuation allowance (295,740) (249,382) (141,618)
Net deferred tax assets 16,666 16,663 16,673
Deferred tax liabilities      
Contractual agreement (16,666) (16,663) (16,673)
Total deferred tax liabilities (16,666) (16,663) (16,673)
Net deferred tax assets $ 0 $ 0 $ 0